Daewoong Pharma (069620) — Financial Flexibility Index
Daewoong Pharma (069620) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of ₩129.75 Billion (operating CF ₩57.53 Billion minus capex ₩72.21 Billion) represents 0% of total liabilities (₩1.26 Trillion). Also explore 069620 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daewoong Pharma Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Daewoong Pharma across 16 annual periods. Check how strategically is Daewoong Pharma's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Daewoong Pharma (2007–2024)
Year-by-year free cash flow to debt coverage for Daewoong Pharma. For the full company profile including market capitalisation, see Daewoong Pharma stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | ₩280.50 Billion | ₩51.49 Billion | ₩1.05 Trillion | ▼ -18.9% |
| 2023 | 0.33x | ₩251.24 Billion | ₩132.57 Billion | ₩762.77 Billion | ▲ +47.6% |
| 2022 | 0.22x | ₩183.44 Billion | ₩118.21 Billion | ₩822.12 Billion | ▲ +130.2% |
| 2021 | 0.10x | ₩69.08 Billion | ₩39.99 Billion | ₩712.77 Billion | ▼ -48.9% |
| 2020 | 0.19x | ₩127.47 Billion | ₩100.98 Billion | ₩671.66 Billion | ▲ +44.8% |
| 2019 | 0.13x | ₩79.91 Billion | ₩57.60 Billion | ₩609.75 Billion | ▼ -24.7% |
| 2018 | 0.17x | ₩104.49 Billion | ₩47.50 Billion | ₩600.04 Billion | ▼ -41.4% |
| 2017 | 0.30x | ₩173.06 Billion | ₩103.94 Billion | ₩581.99 Billion | ▼ -10.1% |
| 2016 | 0.33x | ₩178.63 Billion | ₩15.38 Billion | ₩540.15 Billion | ▼ -8.0% |
| 2015 | 0.36x | ₩131.02 Billion | ₩35.89 Billion | ₩364.29 Billion | ▲ +19.4% |
| 2014 | 0.30x | ₩71.95 Billion | ₩25.95 Billion | ₩238.76 Billion | ▼ -41.9% |
| 2013 | 0.52x | ₩73.20 Billion | ₩54.16 Billion | ₩141.05 Billion | ▼ -27.8% |
| 2012 | 0.72x | ₩68.79 Billion | ₩45.02 Billion | ₩95.76 Billion | ▼ -18.4% |
| 2011 | 0.88x | ₩119.74 Billion | ₩78.82 Billion | ₩136.04 Billion | ▲ +173.8% |
| 2008 | 0.32x | ₩66.67 Billion | ₩31.33 Billion | ₩207.39 Billion | ▼ -35.8% |
| 2007 | 0.50x | ₩61.70 Billion | ₩25.81 Billion | ₩123.24 Billion | — |